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aBStraCt 
Introduction: Clinical laboratory results influence more than 60% of medical decisions, impacting on disease prevention, diagnosis, and 
treatment. The use of quality indicators (QIs) is fundamental for quality assurance, once it allows monitoring the process and directs the 
taking of corrective actions. Objective: Classify the biological sample recollection requests for QIs identification in a clinical laboratory of 
Distrito Federal, Brazil. Material and methods: Data about the requests made in the biennium 2013-2014 were gathered and analyzed. 
Results and discussion: Among the 304,361 samples received, 1,914 (0.62%) had a request for recollection made in accordance with 
laboratory criteria. Most orders originated in the pre-analytical phase (57.7%). The most frequent reason for sample rejection was result 
confirmation (40.7%), followed by insufficient sample (21.9%), coagulated sample (18.1%) and hemolyzed sample (11, 9%). The hematology 
sector was responsible for most recollection requests (43.6%), followed by the biochemistry (29%) and the immunology (25.7%) ones. 
The laboratory emergency department accounted for only 0.1%. Orders were mostly placed by the outpatient clinic (40.7%), emergency 
(30.4%), and internal medicine (12.4%) departments. The percentage of orders is low, but does not exclude the need to reach lower rates. 
Underreporting was detected in the emergency sector, which indicates need for improvement in information registration. Conclusion: 
The numbers mentioned were selected as IQs for the pre-analytical phase, serving as guidelines for future actions taken by the team.
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introDuCtion
The possibility of error occurrence exists in any area of service 
delivery. However, when it comes to the health sector, consequences 
can reach huge proportions. Incorrect laboratory results, for 
example, may cause harm to patients’ health and generate 
additional costs to the institution. Identification of error sources 
is, therefore, necessary for the excellence of results and to ensure 
quality of the services rendered(1).
The tasks carried out at a clinical laboratory are included 
in a dynamic process that begins with specimen collection and 
progresses to reporting of test results. The total testing process 
(TTP) is divided into three phases: pre-analytical, analytical, 
and post-analytical(2). Briefly, the pre-analytical phase begins 
outside the laboratory, with the physician selecting and ordering 
the test, and goes on to sample collection and preparation for 
analysis. The analytical phase comprises a set of operations 
used in the conduction of tests according to a certain method. 
The post-analytical phase encompasses the obtainment of valid 
test results and the report release, for interpretation by the 
clinician(3). Important studies demonstrate that pre- and post-
analytical phases are more prone to error than the analytical 
one. They conclude that TTP evaluation is the best form to 
reduce laboratory errors(4, 5).
The assessment of health services can be done by means of 
indicators, which are numerical measurements of qualitative 
or quantitative errors associated with an event, process or result 
in relation to its total number(6). Classifying errors according to 















priorities for the taking of corrective and preventive actions, so 
ensuring quality improvement(7).
The clinical laboratory currently studied is a support unit of 
the university hospital providing care to the population of Distrito 
Federal (DF) by means of the Unified Health System (SUS). 
Depending on the type of test ordered, samples are analyzed in 
the sectors of biochemistry, emergency, immunology, hematology 
or hormones. Just the hospital’s own demands are satisfied. The 
criteria for ordering sample recollection adopted by the laboratory 
were classified to identify the quality indicators (QIs) for the TTP.
oBjECtivE
The objective of this study was to classify orders for blood 




For the conduction of this study, secondary data were 
retrieved from the laboratory databank on recollection orders 
made between January 2013 and December 2014. The number of 
analyzed samples was 304,361, and the data supplied as reports 
were transferred to a Microsoft Excel spreadsheet version 14.5.0.
The recollection order index was calculated for the biennium. 
We also investigated the distribution of these orders as to year, 
patients’ gender (male/female), age group, hospital area from 
where the requests were placed, and the reasons for recollection. 
The age group was divided into population groups, according to 
a definition by the Ministry of Health(8). For phase classification, 
reasons were divided based on TTP.
Data analysis
For frequency assessment, percentages were calculated. 
The variables with the highest frequencies were selected and 
investigated as to the distribution of reasons for recollection orders. 
rESuLtS
In the period between January 2013 and December 2014, 
304,361 specimens were registered in the sectors of biochemistry, 
emergency, immunology, hematology, and hormones. Among 
them, 1,914 had a recollection order based on a criterion 
employed by the laboratory, representing an index of 0.62% for 
the studied period. 
The distribution of recollection orders according to the 
considered variables can be seen in Table 1.
taBLE 1 − Distribution of recollection orders according






                  Pre-analytical phase
Clotted sample 346 18.1
Sample collected in inadequate tube 15 0.8
Contaminated sample 7 0.4
Hemolized sample 228 11.9
Insufficient sample 420 21.9
Sample not found 86 4.5
Registry error 2 0.1
                      Analytical phase
Lack of reagent 110 5.7
                  Post-analytical phase


















Outpatient department 779 40.7
Nursery 9 0.5
Bronchoscopy 1 0.1
Pediatric surgery 4 0.2
Surgery department 33 1.7
Internal medicine 238 12.4
Adult ER 49 2.6
Pediatric ER 19 1
Dermatology 1 0.1
Emergency department 581 30.4
Hemodialysis 24 1.3
Maternity ward 20 1
Labor medicine 5 0.3
Outpatient pediatric clinic 73 3.8
Pediatric clinic 49 2.6
Chemotherapy 1 0.1
Transplantation 21 1.1
Neonatal ICU 7 0.4
ER: emergency room; ICU: intensive care unit.
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n % n % n % n % n % n % n % n % n % n %
Sex
Female 187 17.5 4 0.3 123 11.5 217 20.3 44 4.1 9 0.8 2 0.1 65 6 415 39 1,066 100
Male 159 18.7 3 0.3 105 12.3 203 23.9 42 4.9 6 0.7 0 0 45 5.3 285 34 848 100
Age group
Children 84 25 1 0.29 41 12.2 137 40.77 2 0.59 2 0.59 0 0 21 6.25 48 14.28 336 100
Adult 133 13.51 6 0.6 96 9.75 156 15.85 63 6.4 8 0.81 1 0.1 60 6.09 461 46.84 984 100
Elderly 119 24.04 0 0 80 16.16 98 19.79 16 3.23 3 0.6 1 0.2 23 4.64 155 31.31 495 100
Laboratory 
sector
Hematology 333 39.8 3 0.3 34 4 276 33 43 5.1 5 0.5 0 0 38 4.5 103 12 835 100
Biochemistry 11 1.9 3 0.5 189 33.9 103 18.5 33 5.9 7 1.2 1 0.1 62 11.1 147 26 556 100





109 13.9 2 0.2 63 8 102 13 55 7 9 1.1 1 0.1 22 2.8 416 53 779 100
Emergency 
department
159 27.3 4 0.6 102 17.5 182 31.3 10 1.7 1 0.1 0 0 56 9.6 67 12 581 100
Internal 
medicine
25 10.5 1 0.4 32 13.4 60 25.2 9 3.7 1 0.4 0 0 13 5.4 97 41 238 100
Recollection orders decreased in 2014. The pre-analytical step 
represented most of the orders. The main reasons for recollection 
were result confirmation, insufficient sample, coagulated sample, 
and hemolyzed sample.
Regarding gender, orders are equally distributed between both 
sexes. Observing the distribution between age groups, most orders 
were placed for adults, elderly people and children.
Concerning the laboratory sector and the origin of the request, 
most request frequencies are distributed among the sectors of 
hematology, biochemistry, and immunology, coming from the 
outpatient clinic, emergency, and internal medicine departments.
The most frequent variables previously cited were investigated 
as to the reasons for the recollection order. According to sex, the 
most common reason was result confirmation (39% for women, 
34% for men), followed by insufficient sample (20.3% for 
women, 23.9% for men), and clotted sample (17.5% for women, 
18.7% for men). The other six reasons amount to less than 20% for 
both sexes (Table 2).
According to age group, the main reason for recollection in 
children was insufficient sample (40.77%). Result confirmation 
represented the highest percentage of reasons for adults (46.84%) 
and the elderly (31.31%).
The main reasons for recollection ordered by the hematology 
sector was clotted sample (39.8%), and insufficient sample (3%); 
for biochemistry, hemolyzed sample (33.9%), insufficient sample 
(18.5%), and lack of reagent (11.1%); for immunology, result 
confirmation (90%).
Samples from the outpatient department had as the main 
reason result confirmation (53%). For the other departments, such 
as emergency, insufficient sample represented 31.3% of reasons; 
and clotted sample, 27.3%. In internal medicine, the reason result 
confirmation had a 41% index, and insufficient sample, a 25.2%.
DiSCuSSion
The rate of repeat collections is very close to that of other 
studies reporting 0.54% and 0.57%(9, 10). They are considered 
low when compared with the 2.7% of a recent study, in which 
55.8% of rejections were caused by sample clotting(11). There are 
no acceptability limits described in the literature(6), but, in the 
current study, the decreased number of recollection orders in 
2014, when compared to 2013, may be explained by the use 
of automated equipment (BC-ROBO-888 Techno Medica®), 
which was installed in the laboratory in 2014. This instrument 
performs specimen labeling in the blood collection room and 
reinforces data observed during the automated pre-analytical 
processes using barcodes, what drastically reduces errors 
associated with this phase(12).
Concerning the distribution of recollection orders according to 
the TTP phase, the result of this study reflects the reality of clinical 
laboratories, regardless of its peculiarities. A recent literature 
review demonstrated that the pre-analytical phase is the main 
error source, and may be responsible for values between 53% and 
75% of the total documented errors. When assessing the financial 
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impact, the study revealed that errors in the pre-analytical phase 
may produce up to 1.2% of the total costs of a hospital(13). 
The most frequent causes of pre-analytical errors described 
in the literature are incorrect identification of the patient 
(49.3%), hemolyzed sample (19.5%), clotted sample (14.2%), 
and insufficient volume (13.7%)(14). Except for the first cause, not 
analyzed in this study because it is not listed in inclusion criteria, 
all the others reflected what happened in the DF laboratory. This 
allows concluding that regardless of the differences between 
laboratories, the main reported problems are similar.
Each of these three variables has great potential to negatively 
influence the quality of laboratory results. Hemolyzed samples 
may be consequence of shaking the tubes during transport, storage 
at incorrect temperatures or for long periods, or even by the use of 
narrow bore needles(15). Improper mixing of tubes may result in 
sample clotting; besides, clots may clog equipment and analysis 
instruments(16). Collection of an inadequate volume may also 
cause blood clotting. For the anticoagulant to perform the expected 
action, it is necessary that the proportion of blood/anticoagulant is 
according to the tube manufacturers’ recommendations. Moreover, 
insufficient sample volumes may preclude the conduction of all 
the ordered tests(13).
As could be observed, the criteria adopted by the laboratory 
do not consider the steps of selection, exam order and patient 
preparation. For some authors, these steps are not part of a pre-
analytical phase, but of a “pre-pre-analytical” one(17). A study 
carried out in the USA investigated the reasons for sample rejection 
in steps prior to collection. Based on a questionnaire answered by 
patients, the main reasons were observed to be inadequate fasting 
(32.2%), and test order missing information (22.5%). Specimens 
difficult to draw, patients leaving collection area before collection, 
and other reasons represent the remaining 45.3%(18). It was 
possible to note that the reasons do not comprise all the steps of the 
pre-analytical phase. Specimens were not reported as to barcodes 
(absent or illegible), adequacy of the collection tube, time between 
collection and analysis, preservation and transport conditions. A 
detailed control of the sample pathway, including the involved 
variables, will provide precise failure detection(2, 11). 
Two steps of the post-analytical phase were not considered: 
result interpretation and appropriate action. Such steps are 
sometimes classified as parts of the “post-post-analytical” 
phase(19). The non-adoption of these steps in the rejection 
criteria of the studied laboratory (reasons for recollection) is 
understood by the fact they are not part of routine of laboratory 
professionals, but of other hospital professionals, such as 
doctors and nurses.
The analysis of the other variables in relation to their 
recollection reasons allowed observing that distribution between 
sexes was homogeneous, and supposing that the high frequency of 
insufficient samples in children may be related to difficult drawing 
and/or low cooperation of pediatric patients.
Concerning sectors, hematology and biochemistry have, in 
the studied laboratory, the highest load of tests to be analyzed. This 
could be a hypothesis to explain the high frequency of recollection 
orders. Nevertheless, when analyzing the distribution of orders 
according to reasons, one notices that in the hematology sector the 
most common cause was clotted sample, and in the biochemistry, 
hemolized sample; both reasons are part of the pre-analytical 
phase, common to both sectors. These notified errors may be 
avoided by corrective actions in the phase before analysis, that is, 
at the phlebotomy moment. 
The immunology sector, on the other hand, has as its main 
reason the result confirmation, which is part of the post-analytical 
phase. This can be explained by the requirements of a Ministry 
of Health directive regarding the procedures for detection of anti-
human immunodeficiency virus (HIV) antibodies in subjects aged 
over 2 years. According to the flow chart of the directive annex 
II, up to four samples may be collected so that the report can be 
released(20).
The low frequency of recollection orders in the emergency 
sector of the laboratory deserves special attention. Given the routine 
speed and the adversities that interfere with sample collection of 
patients from this sector, underreporting of recollection orders is 
believed to have occurred. A study investigating just the indices of 
sample rejection from the emergency sector pointed to an index 
of recollection order of 3.19%, and hemolysis of 65.39% as main 
reason(21). The only two reports observed in the emergency sector 
of the DF laboratory had as the main reason “insufficient sample”.
Unlike what was observed in the DF laboratory, in a study 
carried out in India, the outpatient department had the lowest 
percentage of errors in relation to other sectors of the hospital. It 
is relevant to observe that such a study took into consideration 
just the pre-analytical phase. When considering just this phase, the 
laboratory of the current study also presented low error rates, and 
this may be the result of the automated collection of outpatient 
specimens(22).
ConCLuSion
The recent costs in health services, along with the necessity 
of ensuring citizens’ constitutional rights, are a challenge 
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for managers. In the case of clinical analysis, the use of QIs 
is fundamental. They are a managerial tool whose aim is 
the continuous improvement of all the analyzed steps. Those 
pointed out in this study will be able to help the laboratory 
staff in corrective measures, monitoring and improvement of 
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